Steve C Glover Ambrx Biopharma Inc. (AMAM) insider trading activity

AMAM Quotes by TradingView

Steve C Glover is Director of Ambrx Biopharma Inc.. Currently has a direct ownership of 85,000 shares of AMAM, which is worth approximately $2.38 Million. The most recent transaction as insider was on Jun 07, 2023, when has been sold 85,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85K
0% 3M change
0% 12M change
Total Value Held $2.38 Million

Steve C Glover Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
BUY
Grant, award, or other acquisition
-
85,000 Added 50.0%
85,000 Ordinary Shares

Also insider at

PDSB
PDS Biotechnology Corp Healthcare
LSPR
Larkspur Health Acquisition Corp. Financial Services
Chief Executive Officer
AMAM
Ambrx Biopharma, Inc.
SCG

Steve C Glover

Director
Florham Park, NJ

Track Institutional and Insider Activities on AMAM

Follow Ambrx Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMAM shares.

Notify only if

Insider Trading

Get notified when an Ambrx Biopharma Inc. insider buys or sells AMAM shares.

Notify only if

News

Receive news related to Ambrx Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMAM